1. HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated
   Denise da Rocha Pitta et al, 2013, The International Journal of Biological Markers CrossRef
2. Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4
   Daniel J O’Shannessy et al, 2013, Journal of Ovarian Research CrossRef
3. Alkaline phosphatase labeled antibody-based electrochemical biosensor for sensitive HE4 tumor marker detection
   Michaela Čadková et al, 2015, Electrochemistry Communications CrossRef
4. CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor
   Banu Deveci et al, 2019, Turkish Journal of Biochemistry CrossRef
5. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
   Junli Deng et al, 2013, Cancer and Metastasis Reviews CrossRef
6. Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
   Fiona Collinson et al, 2013, Clinical Cancer Research CrossRef
7. Sensor detection in gynaecological medicine
   Michael Thompson et al, 2022, Sensors & Diagnostics CrossRef
8. Quantification of ovarian cancer markers with integrated microfluidic concentration gradient and imaging nanohole surface plasmon resonance
   Carlos Escobedo et al, 2013, The Analyst CrossRef
9. ROMA, an algorithm for ovarian cancer
   Anita Monika Chudecka-Głaz, 2015, Clinica Chimica Acta CrossRef
10. Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy
    Tatsuya Hanaoka et al, 2017, Molecular Diagnosis & Therapy CrossRef
11. On-chip nanohole array based sensing: a review
    Carlos Escobedo, 2013, Lab on a Chip CrossRef
12. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
    Michihiko Aoyama et al, 2019, mAbs CrossRef
13. Ultrasensitive Detection of Ovarian Cancer Biomarker Using Au Nanoplate SERS Immunoassay
    Gayoung Eom et al, 2021, BioChip Journal CrossRef
14. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients
    Karolina Okła et al, 2018, Tumor Biology CrossRef